Urinary profile of methylprednisolone and its metabolites after oral and topical administrations

Journal of Steroid Biochemistry and Molecular Biology

Volumn 138, Issue , 2013, Pages 214-221

  Matabosch, Xavier ^a   Pozo, Oscar J ^a   Monfort, Núria ^a   Pérez Mañá, Clara ^b,c   Farré, Magi ^b,c   Marcos, Josep ^a,d   Segura, Jordi ^a,d   Ventura, Rosa ^a,d  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Doping; LC MS MS; Metabolites; Methylprednisolone; Routes of administration

Indexed keywords

16BETA,17ALPHA,21 TRIHYDROXY 6ALPHA METHYLPREGNA 1,4 DIENE 3,11,20 TRIONE; 17ALPHA,20ALPHA,21 TRIHYDROXY 6ALPHA METHYLPREGNA 1,4 DIENE 3,11 DIONE; ADVENTAM; DRUG METABOLITE; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACEPONATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CROSSOVER PROCEDURE; DRUG EXCRETION; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; LOW DRUG DOSE; MALE; NORMAL HUMAN; PERCEPTIVE DISCRIMINATION; QUADRUPOLE MASS SPECTROMETRY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; URINARY EXCRETION;

DOPING; LC-MS/MS; METABOLITES; METHYLPREDNISOLONE; ROUTES OF ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; CHROMATOGRAPHY, LIQUID; HUMANS; MALE; MASS SPECTROMETRY; METHYLPREDNISOLONE; YOUNG ADULT;

EID: 84880181378     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.05.019     Document Type: Article

References (31)

1. B. Kirby A review of the rational use of corticosteroids Journal of International Medical Research 17 1989 493 505 (Pubitemid 20006331)
2. C. Gunther, A. Kecskes, T. Staks, and U. Tauber Percutaneous absorption of methylprednisolone aceponate following topical application of Advantan lotion on intact, inflamed and stripped skin of male volunteers Skin Pharmacology and Physiology 11 1998 35 42 (Pubitemid 28266288)
3. T. Luger, K.D. Loske, P. Elsner, A. Kapp, M. Kerscher, H.C. Korting, J. Krutmann, R. Niedner, M. Rocken, T. Ruzicka, and T. Schwarz Topical skin therapy with glucocorticoids-therapeutic index Journal der Deutschen Dermatologischen Gesellschaft 2 2004 629 634 (Pubitemid 38931700)
4. T. Bieber, K. Vick, R. Folster-Holst, A. Belloni-Fortina, G. Stadtler, M. Worm, and F. Arcangeli Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis Allergy 62 2007 184 189 (Pubitemid 46090301)
5. T. Ruzicka Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update International Journal of Clinical Practice 60 2006 85 92 (Pubitemid 43732581)
6. B. Pluim A doping sinner is not always a cheat British Journal of Sports Medicine 42 2008 549 550 (Pubitemid 352000926)
7. H. Kuipers, and B. Pluim Corticosteroid administration and exercise performance Medicine & Science in Sports & Exercise 40 2008 773-
8. M. Duclos Glucocorticoids: a doping agent? Endocrinology and Metabolism Clinics of North America 39 2010 107 126
9. The World Anti-Doping Code The 2013 Prohibited List. International Standard [World Anti-Doping Agency Web site] 2013 Available at: http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP-Prohibited- list/2013/WADA-Prohibited-List-2013-EN.pdf (accessed 06.02.13)
10. Minimum required performance levels for detection of prohibited substances [World Anti-Doping Agency Web site] 2013 Available at: http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP-IS- Laboratories/Technical-Documents/WADA-TD2013MRPL-Minimum-Required-Performance- Levels-v1-2012-EN.pdf (accessed 06.02.13)
11. K. Deventer, P. Mikulcikova, H. Van Hoecke, P. Van Eenoo, and F.T. Delbeke Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry Journal of Pharmaceutical and Biomedical Analysis 42 2006 474 479 (Pubitemid 44375111)
12. X. Matabosch, O.J. Pozo, C. Perez-Mana, M. Farre, J. Marcos, J. Segura, and R. Ventura Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports Therapeutic Drug Monitoring 35 2013 118 128
13. R. Berges, J. Segura, X. de la Torre, and R. Ventura Analytical methodology for enantiomers of salbutamol in human urine for application in doping control Journal of Chromatography B Biomedical Sciences and Applications 723 1999 173 184 (Pubitemid 29148120)
14. R. Berges, J. Segura, R. Ventura, K.D. Fitch, A.R. Morton, M. Farre, M. Mas, and X. de la Torre Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment Clinical Chemistry 46 2000 1365 1375
15. R. Ventura, J. Segura, R. Berges, K.D. Fitch, A.R. Morton, S. Berruezo, and C. Jimenez Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control Therapeutic Drug Monitoring 22 2000 277 282 (Pubitemid 30346443)
16. A. Panusa, G. Aldini, M. Orioli, G. Vistoli, G. Rossoni, and M. Carini A sensitive and specific precursor ion scanning approach in liquid chromatography/electrospray ionization tandem mass spectrometry to detect methylprednisolone acetate and its metabolites in rat urine Rapid Communications in Mass Spectrometry 24 2010 1583 1594
17. A. Panusa, M. Orioli, G. Aldini, and M. Carini A rapid and sensitive LC-ESI-MS/MS method for detection and quantitation of methylprednisolone and methylprednisolone acetate in rat plasma after intra-articular administration Journal of Pharmaceutical and Biomedical Analysis 51 2010 691 697
18. G.M. Rodchenkov, V.P. Uralets, and V.A. Semenov Determination of methylprednisolone metabolites in human urine by gas chromatography-mass spectrometry Journal of Chromatography 423 1987 15 22 (Pubitemid 18026278)
19. T.B. Vree, C.P. Verwey-van Wissen, A.J. Lagerwerf, A. Swolfs, R.A. Maes, R.D. van Ooijen, O.R. van Eikema Hommes, and P.J. Jongen Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy Journal of Chromatography B Biomedical Sciences and Applications 726 1999 157 168 (Pubitemid 29187217)
20. O.J. Pozo, R. Ventura, N. Monfort, J. Segura, and F.T. Delbeke Evaluation of different scan methods for the urinary detection of corticosteroid metabolites by liquid chromatography tandem mass spectrometry Journal of Mass Spectrometry 44 2009 929 944
21. A. Panusa, L. Regazzoni, G. Aldini, M. Orioli, A. Giombini, P. Minghetti, C. Tranquilli, and M. Carini Urinary profile of methylprednisolone acetate metabolites in patients following intra-articular and intramuscular administration Analytical and Bioanalytical Chemistry 400 2011 255 267
22. O.J. Pozo, J. Marcos, X. Matabosch, R. Ventura, and J. Segura Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine Rapid Communications in Mass Spectrometry 26 2012 541 553
23. R.N. Goyal, M. Oyama, A.A. Umar, A. Tyagi, and N. Bachheti Determination of methylprednisolone acetate in biological fluids at gold nanoparticles modified ITO electrode Journal of Pharmaceutical and Biomedical Analysis 44 2007 1147 1153 (Pubitemid 47239309)
24. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures: Text and Methodology 1996 ICH-Q2B Geneva
25. S.C. Sweetman Martindale The Complete Drug Reference 2011 The Pharmaceutical Press London
26. J.P. Ortonne Safety aspects of topical methylprednisolone aceponate (MPA) treatment Journal of Dermatological Treatment 3 1992 21 25
27. R.L. Taylor, S.K. Grebe, and R.J. Singh Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids Clinical Chemistry 50 2004 2345 2352 (Pubitemid 39552171)
28. M.E. Touber, M.C. van Engelen, C. Georgakopoulus, J.A. van Rhijn, and M.W. Nielen Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry Analytica Chimica Acta 586 2007 137 146 (Pubitemid 46240017)
29. J.H. Andersen, L.G. Hansen, and M. Pedersen Optimization of solid phase extraction clean up and validation of quantitative determination of corticosteroids in urine by liquid chromatography-tandem mass spectrometry Analytica Chimica Acta 617 2008 216 224
30. M. Mazzarino, S. Turi, and F. Botre A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography-mass spectrometry based on class-characteristic fragmentation pathways Analytical and Bioanalytical Chemistry 390 2008 1389 1402
31. A. Tolgyesi, V.K. Sharma, L. Kovacsics, and J. Fekete Quantification of corticosteroids in bovine urine using selective solid phase extraction and reversed-phase liquid chromatography/tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 878 2010 1471 1479